Crossmark

Exploring the antitumor potential of cucurbitacin B in hepatocellular carcinoma through network pharmacology, molecular docking, and molecular dynamics simulations

Crossref DOI link: https://doi.org/10.1007/s00210-025-04273-x

Published Online: 2025-05-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Hongyu

Wu, Baixiu

Ke, Liuhua

Fan, Xiaoyuan

Huang, Liji

Peng, Zheng
License Information

Text and Data Mining valid from 2025-05-21

Version of Record valid from 2025-05-21
More Information

Article History

Received: 2 April 2025

Accepted: 6 May 2025

First Online: 21 May 2025

Declarations

:

: The study did not involve human or animal experimentation and did not require an ethical review.

: Informed consent was obtained from all participants.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below